PMC:7696151 / 52390-52519
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1505 | 14-18 | Species | denotes | mice | Tax:10090 |
| 1512 | 40-43 | Chemical | denotes | HCQ | MESH:D006886 |
| 1538 | 28-33 | Disease | denotes | lupus | MESH:D008180 |
| 1539 | 107-121 | Disease | denotes | thromboembolic | MESH:D013923 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T90 | 107-128 | Phenotype | denotes | thromboembolic events | http://purl.obolibrary.org/obo/HP_0001907 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T335 | 0-129 | Sentence | denotes | In a NZB/W F1 mice model of lupus, oral HCQ gavage of 10 mg/kg/day for five weeks reduced the incidence of thromboembolic events. |